ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,264, issued on Dec. 9, was assigned to Duke University (Durham, N.C.).
"Compositions and methods for the diagnosis and treatment of retinopathies" was invented by Jeremy Kay (Durham, N.C.) and Thomas Ray (Durham, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods related to the cell surface protein CRB1 for the treatment of retinopathies in a subject, as well as systems and kits employing such compositions."
The patent was filed on March 4, 2020, under Application No. 17/436,419.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Pa...